Two Sigma Advisers’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-32,600
Closed -$120K – 2723
2023
Q1
$120K Sell
32,600
-193,800
-86% -$816K ﹤0.01% 2356
2022
Q4
$401K Sell
226,400
-23,400
-9% -$62.2K ﹤0.01% 1966
2022
Q3
$989K Sell
249,800
-53,800
-18% -$331K ﹤0.01% 1526
2022
Q2
$1.68M Buy
303,600
+142,900
+89% +$1.17M ﹤0.01% 1302
2022
Q1
$2.36M Sell
160,700
-147,300
-48% -$1.97M 0.01% 1163
2021
Q4
$4.87M Buy
308,000
+190,200
+161% +$4.57M 0.01% 780
2021
Q3
$3.78M Buy
117,800
+82,900
+238% +$2.91M 0.01% 922
2021
Q2
$1.45M Buy
+34,900
New +$1.43M ﹤0.01% 1459

Other funds holding DMTK

Two Sigma Advisers's DMTK Position: Q2 2023 in Review

Two Sigma Advisers sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2023, closing a stake of 32,600 shares — an estimated $120K sold.

Two Sigma Advisers first reported a position in DMTK in Q2 2021 and held it in 8 quarters. The position peaked at $4.87M in Q4 2021. 85 funds tracked by Wall St. Rank hold DMTK as of Q2 2023.

  • Two Sigma Advisers reported no remaining DermTech, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 32,600 DermTech, Inc. Common Stock shares in Q2 2023, an estimated $120K.
  • Two Sigma Advisers first reported a position in DermTech, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • Two Sigma Advisers's DermTech, Inc. Common Stock position peaked at $4.87M in Q4 2021.
  • 85 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2023.

Based on Two Sigma Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.